Metal Metabolism Disorders
Gene: FTL
Well-established gene-disease association (see OMIM entry). Neuroferritinopathy is classified as a metabolic disorder by the NIH GARD (https://rarediseases.info.nih.gov/diseases/diseases-by-category/14/metabolic-disorders).Created: 4 Feb 2021, 11:46 p.m. | Last Modified: 4 Feb 2021, 11:46 p.m.
Panel Version: 0.22
Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Phenotypes
Hyperferritinemia-cataract syndrome MIM#600886; L-ferritin deficiency, dominant and recessive MIM#615604; Neurodegeneration with brain iron accumulation 3 MIM#606159
Publications
Gene: ftl has been classified as Green List (High Evidence).
gene: FTL was added gene: FTL was added to Iron metabolism disorders. Sources: Genomics England PanelApp,Expert Review Green,NHS Genomic Medicine Service Mode of inheritance for gene: FTL was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Publications for gene: FTL were set to 23940258; 18413574; 23421845; 19176363 Phenotypes for gene: FTL were set to 606159 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; LFTD; NBIA3; 615604 L-FERRITIN DEFICIENCY; HRFTC; 606159 Neurodegeneration with brain iron accumulation 3; 600886 HYPERFERRITINEMIA WITH OR WITHOUT CATARACT; 600886 Hyperferritinemia-cataract syndrome; 615604 L-ferritin deficiency, dominant and recessive